home / stock / clrb / clrb news

CLRB News and Press, Cellectar Biosciences Inc. From 11/02/23

Stock Information
Company Name: Cellectar Biosciences Inc.
Stock Symbol: CLRB
Market: NASDAQ
Website: cellectar.com
Menu
CLRB CLRB Quote CLRB Short CLRB News CLRB Articles CLRB Message Board
Get CLRB Alerts

News, Short Squeeze, Breakout and More Instantly...
CLRB - Cellectar Biosciences, Inc. (CLRB) Q3 2023 Earnings Call Transcript

2023-11-02 14:19:05 ET Cellectar Biosciences, Inc. (CLRB) Q3 2023 Earnings Conference Call November 02, 2023, 08:30 ET Company Participants Monique Kosse - LifeSci Advisors James Caruso - CEO Chad Kolean - CFO Shane Lea - CCO Andrei Shustov - SVP, Medical...
CLRB - Cellectar to Release Top-line Data from WM Pivotal Trial During the JP Morgan Healthcare Conference the Week of January 8, 2024

Reports Preliminary Financial Results for Third Quarter 2023 and Provides a Corporate Update Conference Call scheduled for today at 8:30 am Eastern Time FLORHAM PARK, N.J., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical bio...

CLRB - Expected US Company Earnings on Thursday, November 2nd, 2023

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

CLRB - Expected earnings - Cellectar Biosciences Inc.

Cellectar Biosciences Inc. (CLRB) is expected to report $-0.44 for Q3 2023
CLRB - Cellectar Biosciences Q3 2023 Earnings Preview

2023-11-01 14:15:25 ET More on Cellectar Biosciences Seeking Alpha’s Quant Rating on Cellectar Biosciences Historical earnings data for Cellectar Biosciences Financial information for Cellectar Biosciences For further details see: Cellectar Bioscie...

CLRB - Notable earnings before Thursday's open

2023-11-01 11:48:22 ET Major earnings expected before the bell on Thursday include: Barrick Gold ( GOLD ) Moderna ( MRNA ) Palantir Technologies ( PLTR ) Starbucks ( SBUX ) Shopify ( SHOP ) For further details see: Notable earnings before ...

CLRB - Cellectar Biosciences Partners with Florida Cancer Specialists & Research Institute to Support the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting

Strategic collaboration to advance patient care and further define the U.S. treatment landscape First of several planned community-based cancer care network collaborations for Cellectar to facilitate future patient access and clinical success with iopofosine I 131 FLORHAM PARK, N....
CLRB - Cellectar Biosciences to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 2, 2023

FLORHAM PARK, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of targeted drugs for the treatment of cancer, today announced that the company will repor...

CLRB - Cellectar Biosciences Expands Commercialization Leadership Team Ahead of Pivotal Data for Iopofosine I-131 in Waldenstrom's Macroglobulinemia

William Yoon Appointed Vice President, Medical Affairs Aaditya Nanduri Appointed Vice President, Business Strategy and Analytics FLORHAM PARK, N.J., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focuse...

CLRB - Cellectar Biosciences files to sell 34.5M shares for holders

2023-10-05 16:56:44 ET More on Cellectar Biosciences Seeking Alpha’s Quant Rating on Cellectar Biosciences Historical earnings data for Cellectar Biosciences Financial information for Cellectar Biosciences For further details see: Cellectar Bioscie...
Previous 10 Next 10